Safety Evaluation of LB20304, a New Quinolone Antibiotic

  • Kim, Seong-Il (Biotech Research Institute, LG Chem Research Park, LG Chemical Ltd.) ;
  • Kim, Hee-Jin (Biotech Research Institute, LG Chem Research Park, LG Chemical Ltd.) ;
  • Kwak, Jin-Hwan (Biotech Research Institute, LG Chem Research Park, LG Chemical Ltd.) ;
  • Kim, In-Chull (Biotech Research Institute, LG Chem Research Park, LG Chemical Ltd.) ;
  • Lee, Chang-Ho (Biotech Research Institute, LG Chem Research Park, LG Chemical Ltd.)
  • Published : 1995.12.01

Abstract

General pharmacology of LB20304, a quinolone antibiotic, were examined in terms of general behaviour, cardiovascular, and central nervous system. LB20304 at oral dose of 2,000 mg/kg did not induce significant behavioural changes in mice. In contrast with ciprofloxacin, LB20304 at dose of 20 mg/kg, iv. did not show any observable effects on the blood pressure in rats. Displacement of [$^3$H]muscimol binding to the rat brain synaptic membranes was measured. LB20304 was shown to be about five times less potent than ciprofloxacin in specific GABA receptor binding. Drug interaction between LB20304 and 4-biphenyl acetic acid, an active metabolite of fenbufen, was assessed in mice by measuring convulsion and/or subsequent death. A single oral pretreatment with 4-BPA at 400 mg/kg increased the incidence of convulsion and death after oral administration of ciprofloxacin at the doses of 25, 50, and 100 from zero of five to three of five, two of five, and four of five, respectively, whereas LB20304 alone or combination with 4-BPA caused neither convulsions nor death at the doses of 12.5, 25, 50, and 100 mg/kg, respectively. Quinolones-induced epileptogenic activities were assessed by a direct intracerebral injection of test articles. The CD$_{50}$ values (nmole) are as follows; 169.47, 35.36, 105.29, and 88.67 for LB20304, ciprofloxacin, of loxacin, and lomefloxacin, respectively. From these data, LB 20304 at therapeutic doses seems to be much more safe than any other quinolones tested.d.

Keywords